These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34285121)

  • 1. T-Cell Expression and Release of Kidney Injury Molecule-1 in Response to Glucose Variations Initiates Kidney Injury in Early Diabetes.
    Forbes JM; McCarthy DA; Kassianos AJ; Baskerville T; Fotheringham AK; Giuliani KTK; Grivei A; Murphy AJ; Flynn MC; Sullivan MA; Chandrashekar P; Whiddett R; Radford KJ; Flemming N; Beard SS; D'Silva N; Nisbet J; Morton A; Teasdale S; Russell A; Isbel N; Jones T; Couper J; Healy H; Harris M; Donaghue K; Johnson DW; Cotterill A; Barrett HL; O'Moore-Sullivan T
    Diabetes; 2021 Aug; 70(8):1754-1766. PubMed ID: 34285121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products as predictors of renal function in youth with type 1 diabetes.
    Forbes JM; Le Bagge S; Righi S; Fotheringham AK; Gallo LA; McCarthy DA; Leung S; Baskerville T; Nisbett J; Morton A; Teasdale S; D'Silva N; Barrett H; Jones T; Couper J; Donaghue K; Isbel N; Johnson DW; Donnellan L; Deo P; Akison LK; Moritz KM; O'Moore-Sullivan T
    Sci Rep; 2021 May; 11(1):9422. PubMed ID: 33941808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor Glycemic Control Is Associated With More Rapid Kidney Function Decline After the Onset of Diabetic Kidney Disease.
    Shah HS; McGill JB; Hirsch IB; Wu C; Galecki A; de Boer IH; Mauer M; Doria A
    J Clin Endocrinol Metab; 2024 Jul; 109(8):2124-2135. PubMed ID: 38262002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid decline of kidney function in diabetic kidney disease is associated with high soluble Klotho levels.
    Bob F; Schiller A; Timar R; Lighezan D; Schiller O; Timar B; Bujor CG; Munteanu M; Gadalean F; Mihaescu A; Grosu I; Hategan A; Chisavu L; Pusztai AM; Covic A
    Nefrologia (Engl Ed); 2019; 39(3):250-257. PubMed ID: 30396700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.
    Coca SG; Nadkarni GN; Huang Y; Moledina DG; Rao V; Zhang J; Ferket B; Crowley ST; Fried LF; Parikh CR
    J Am Soc Nephrol; 2017 Sep; 28(9):2786-2793. PubMed ID: 28476763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
    de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
    Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing equivalent diabetes in male and female Nos3-deficient mice results in a comparable onset of diabetic kidney injury.
    Tian L; Nikolic-Paterson DJ; Tesch GH
    Physiol Rep; 2019 Sep; 7(18):e14197. PubMed ID: 31535473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease.
    Gohda T; Kamei N; Koshida T; Kubota M; Tanaka K; Yamashita Y; Adachi E; Ichikawa S; Murakoshi M; Ueda S; Suzuki Y
    J Diabetes Investig; 2020 Mar; 11(2):435-440. PubMed ID: 31483944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated urinary N-acetyl-β-D-glucosaminidase is associated with high glycoalbumin-to-hemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease.
    Hong N; Lee M; Park S; Lee YH; Jin SM; Kim JH; Lee BW
    Sci Rep; 2018 Apr; 8(1):6710. PubMed ID: 29712934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy.
    Bian X; Griffin TP; Zhu X; Islam MN; Conley SM; Eirin A; Tang H; O'Shea PM; Palmer AK; McCoy RG; Herrmann SM; Mehta RA; Woollard JR; Rule AD; Kirkland JL; Tchkonia T; Textor SC; Griffin MD; Lerman LO; Hickson LJ
    BMJ Open Diabetes Res Care; 2019; 7(1):e000720. PubMed ID: 31908790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of blood glucose and renal end points in advanced diabetic kidney disease.
    Kornelius E; Lo SC; Huang CN; Wang YH; Yang YS
    Diabetes Res Clin Pract; 2020 Mar; 161():108011. PubMed ID: 31991151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach.
    Carlsson AC; Nowak C; Lind L; Östgren CJ; Nyström FH; Sundström J; Carrero JJ; Riserus U; Ingelsson E; Fall T; Ärnlöv J
    Ups J Med Sci; 2020 Feb; 125(1):37-43. PubMed ID: 31805809
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary Renin in Patients and Mice With Diabetic Kidney Disease.
    Tang J; Wysocki J; Ye M; Vallés PG; Rein J; Shirazi M; Bader M; Gomez RA; Sequeira-Lopez MS; Afkarian M; Batlle D
    Hypertension; 2019 Jul; 74(1):83-94. PubMed ID: 31079532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs may impact podocytes and proximal tubule function through modulating miRNAs expression in Early Diabetic Kidney Disease of Type 2 Diabetes Mellitus patients.
    Petrica L; Hogea E; Gadalean F; Vlad A; Vlad M; Dumitrascu V; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Jianu DC; Matusz P; Pusztai AM; Motoc A; Cretu OM; Radu D; Milas O; Golea-Secara A; Simulescu A; Mogos-Stefan M; Patruica M; Balint L; Ienciu S; Vlad D; Popescu R
    Int J Med Sci; 2021; 18(10):2093-2101. PubMed ID: 33859515
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes.
    Sabbisetti VS; Waikar SS; Antoine DJ; Smiles A; Wang C; Ravisankar A; Ito K; Sharma S; Ramadesikan S; Lee M; Briskin R; De Jager PL; Ngo TT; Radlinski M; Dear JW; Park KB; Betensky R; Krolewski AS; Bonventre JV
    J Am Soc Nephrol; 2014 Oct; 25(10):2177-86. PubMed ID: 24904085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes.
    Panduru NM; Sandholm N; Forsblom C; Saraheimo M; Dahlström EH; Thorn LM; Gordin D; Tolonen N; Wadén J; Harjutsalo V; Bierhaus A; Humpert PM; Groop PH;
    Diabetes Care; 2015 Jun; 38(6):1130-7. PubMed ID: 25784666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway.
    Li X; Xu B; Wu J; Pu Y; Wan S; Zeng Y; Wang M; Luo L; Zhang F; Jiang Z; Xu Y
    Oxid Med Cell Longev; 2022; 2022():7177889. PubMed ID: 35498124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease.
    Zhang H; Hu W; Zhang G
    Int Urol Nephrol; 2020 Aug; 52(8):1517-1522. PubMed ID: 32458209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.